Guaraldi, G. http://orcid.org/0000-0002-5724-3914
Malagoli, A.
Calcagno, A.
Mussi, C.
Celesia, B. M.
Carli, F.
Piconi, S.
De Socio, G. V.
Cattelan, A. M.
Orofino, G.
Riva, A.
Focà, E.
Nozza, S.
Di Perri, G.
Article History
Received: 26 July 2017
Accepted: 12 April 2018
First Online: 20 April 2018
Authors’ information
: Giovanni Guaraldi, MD, is Associate Professor of Infectious disease at the University of Modena and Reggio Emilia. Since the year 2000, he has lead the Modena HIV Metabolic Clinic (MHMC). This referral centre offers a multidisciplinary team approach to HIV patients with metabolic abnormalities, and it offers a multidimensional evaluation of ageing HIV infected patients. More than 4500 patients are followed at this Centre.Prof. Guaraldi published over 300 peer reviewed papers mainly focused on frailty and HIV associated co-morbidities.In 2016 he built the first HIV geriatric cohort in Italy called: Geriatric Patients Living with HIV/AIDS (GEPPO).Two peer reviewed papers have been published.about this new prospective observational multicentre cohort:OrderedList removed
: The study received approval from Comitato Etico Provinciale di Modena.Study 39/2016. IRB approval: Prot.1710 of 10 May 2016.Written informed consent was obtained from participants.
: The paper contains aggregated data only.
: GG received research grants from ViiV Healthcare, Gilead, Merck Sharp and Dohme (MSD). Talks grants from ViiV Healthcare, Gilead, Merck Sharp and Dohme, Jansen, BMS. Consultation to ViiV Healthcare, Gilead, Merck Sharp and Dohme. CA received grants, travel grants and speaker’s honoraria from Abbvie, BMS, Gilead, ViiV Healthcare, Janssen-Cilag and MSD. CBM received grants, travel grants and speaker’s honoraria from Abbvie, BMS, Gilead, ViiV Healthcare, Janssen-Cilag and MSD. DSGV received travel grants from Abbvie, BMS, Gilead, ViiV Healthcare, Janssen-Cilag and MSD. CAM received grants and speaker’s honoraria from Abbvie, BMS, Gilead, ViiV Healthcare, Janssen-Cilag and MSD. NS received travel grants and speaker’s honoraria from Abbvie, BMS, Gilead, ViiV Healthcare, Janssen-Cilag and MSD. OG received travel grants and speaker’s honoraria from Abbvie, BMS, Gilead, ViiV Healthcare, Janssen-Cilag and MSD. RA grants, travel grants and speaker’s honoraria from BMS, Gilead, ViiV Healthcare, Janssen-Cilag, Novartis and MSD. FE received travel grants and speaker’s honoraria from BMS, Gilead, ViiV Healthcare, Janssen-Cilag and MSD. DPG received grants, travel grants and speaker’s honoraria from Abbvie, BMS, Gilead, ViiV Healthcare, Janssen-Cilag and MSD. MA, MC, CF, PS reported no potential conflict of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.